Private equity firm EQT increases offer for Sweden’s Karo Pharma

2 Jan 2019

Private equity firm EQT on
Wednesday bumped up its offer for Swedish specialty pharma group
Karo Pharma to 6.15 billion Swedish crowns ($694
million), citing in part stock market performance since its
original offer two months ago.

Read full article at Reuters